“…Unfortunately, that trial was closed prematurely because of recruitment issues, and it consequently lacked the power to provide evidence for any clinical benefit of FNT over photon radiotherapy. Recently, Ragulin et al [ 10 ] conducted a phase II trial in Russia, which included 201 patients, comparing mixed photon-FNT radiotherapy with photon radiotherapy for inoperable, locally advanced breast cancer, mostly T4N + tumors. That trial showed a significant increase of 10-year overall survival (OS) and 10-year disease-free survival (DFS) in the photon-FNT group (10-y OS, 32.8% versus 17.1%, P < .02; 10-y DFS, 29.5% versus 4.4%, P < .02), whereas the toxicity profiles were strictly comparable between each group.…”